Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Last revisionBoth sides next revision
multiomics_analysis_for_dementia [2021/04/08 17:56] – [Subprojects] ishamultiomics_analysis_for_dementia [2021/10/26 05:52] – [Data] admin
Line 12: Line 12:
  
   - The Cohorts for Heart and Aging Research in Genomic Epidemiology ([[http://www.chargeconsortium.com|CHARGE]]) Consortium.   - The Cohorts for Heart and Aging Research in Genomic Epidemiology ([[http://www.chargeconsortium.com|CHARGE]]) Consortium.
-  - The Trans-Omics for Precision Medicine ([[https://www.nhlbiwgs.org|TOPMed]]) program. The TOPMed Omics [[http://oncinfo.org/_media/wiki:topmed_omics_survey.pdf|Survey]] in 2017 includes Framingham Heart Study (FHS) details, which are described clearer in [[http://oncinfo.org/_media/wiki:omics_fhs.pdf|2016]]. [[https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/molecular.cgi?study_id=phs000363.v17.p11&phv=173423&phd=4119&pha=&pht=2941&phvf=&phdf=&phaf=&phtf=&dssp=1&consent=&temp=1|SABRe]] is a substudy of FHS and has mRNA and miRNA data. We obtained [[https://docs.google.com/document/d/1B8uKY2QBuJHAiPrv9y_cR9704RrI7nZM71oVc7jt5Q8/edit|these]] data in 2019.+  - The Trans-Omics for Precision Medicine ([[https://www.nhlbiwgs.org|TOPMed]]) program. The TOPMed Omics [[http://oncinfo.org/_media/wiki:topmed_omics_survey.pdf|Survey]] in 2017 includes Framingham Heart Study (FHS) details, which are described clearer in [[http://oncinfo.org/_media/wiki:omics_fhs.pdf|2016]]. [[https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/molecular.cgi?study_id=phs000363.v17.p11&phv=173423&phd=4119&pha=&pht=2941&phvf=&phdf=&phaf=&phtf=&dssp=1&consent=&temp=1|SABRe]] is a substudy of FHS and has mRNA and miRNA data. We obtained [[https://docs.google.com/document/d/1B8uKY2QBuJHAiPrv9y_cR9704RrI7nZM71oVc7jt5Q8/edit|these]] data in 2019. On 2021-04-23, {{:fhs_multiomics_meeting_msevilla_april21.pdf|Magdalena}}  Sevilla presented a collection of FHS, MESA, and WHI omics datasets and some statistical methods for analyzing them.
   - Exome Sequencing Project ([[http://evs.gs.washington.edu|ESP]]), richly-phenotyped for heart, lung and blood disorders.   - Exome Sequencing Project ([[http://evs.gs.washington.edu|ESP]]), richly-phenotyped for heart, lung and blood disorders.
   - Alzheimer's Disease Sequencing Project ([[https://www.niagads.org/adsp/content/study-design|ADSP]]), WES and WGS of thousands of AD and control samples.   - Alzheimer's Disease Sequencing Project ([[https://www.niagads.org/adsp/content/study-design|ADSP]]), WES and WGS of thousands of AD and control samples.
Line 28: Line 28:
   - Omics data were generated in [[https://www.neurodegenerationresearch.eu/it/cohort/the-rhineland-study/|Rhineland]] Study including DNA methylation from ~2K blood samples. Aslam Imtiaz presented these data in the NeuroCHARGE call on 2019-11-07.   - Omics data were generated in [[https://www.neurodegenerationresearch.eu/it/cohort/the-rhineland-study/|Rhineland]] Study including DNA methylation from ~2K blood samples. Aslam Imtiaz presented these data in the NeuroCHARGE call on 2019-11-07.
   - [[https://bmbls.bmi.osumc.edu/scread/|scREAD]]: A Single-Cell RNA-Seq Database for Alzheimer’s Disease ([[https://www.cell.com/iscience/pdf/S2589-0042(20)30966-4.pdf|pdf]]). It covers 73 datasets from 15 studies, 10 brain regions, 713640 cells.Useful for: a) listing available datasets, b) easy preliminary DE analysis across cell types and disease vs. control conditions.   - [[https://bmbls.bmi.osumc.edu/scread/|scREAD]]: A Single-Cell RNA-Seq Database for Alzheimer’s Disease ([[https://www.cell.com/iscience/pdf/S2589-0042(20)30966-4.pdf|pdf]]). It covers 73 datasets from 15 studies, 10 brain regions, 713640 cells.Useful for: a) listing available datasets, b) easy preliminary DE analysis across cell types and disease vs. control conditions.
 +  - [[https://www.nature.com/articles/s41586-021-03910-8|Bhaduri]] 's 2021 snRNASeq of the developing human brain.
  
  
Line 52: Line 53:
   - Borghesan, M., et al. "A **Senescence**-Centric View of Aging: Implications for Longevity and Disease." [[https://www.sciencedirect.com/science/article/abs/pii/S0962892420301434|Trends in Cell Biology]] (2020). The review paper suggested by Christi.   - Borghesan, M., et al. "A **Senescence**-Centric View of Aging: Implications for Longevity and Disease." [[https://www.sciencedirect.com/science/article/abs/pii/S0962892420301434|Trends in Cell Biology]] (2020). The review paper suggested by Christi.
  
- 
-===== Related work ===== 
- 
-  - An interactive **timeline**  of Alzheimer's disease by [[https://www.alzforum.org/timeline/alzheimers-disease#2010|AlzForum]]. 
-  - Satizabal, Claudia L., et al. "Genetic architecture of subcortical brain structures in 38,851 individuals." //[[https://www.nature.com/articles/s41588-019-0511-y|Nature genetics]]// 51.11 (2019): 1624-1636. \\ They identified a set of genes that is "significantly enriched for //Drosophila//  orthologs associated with neurodevelopmental phenotypes". 
-  - Yamazaki, Yu., et al. "Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies." [[https://www.nature.com/articles/s41582-019-0228-7|Nat Rev Neurol ]](2019): 501–518. 
-  - Ferreira, Daniel., et al. Biological subtypes of Alzheimer disease: A systematic review and meta-analysis [[https://n.neurology.org/content/neurology/early/2020/02/11/WNL.0000000000009058.full.pdf|Neurology]] (2020):94:1-13. 
-  - Sey, Nancy YA, et al. A computational tool (H-MAGMA) for improved prediction of brain-disorder risk genes by incorporating brain chromatin interaction profiles. [[https://www.nature.com/articles/s41593-020-0603-0|Nature Neuroscience]], 2020. 
-  - Borghesan, M., et al. "A **Senescence**-Centric View of Aging: Implications for Longevity and Disease." [[https://www.sciencedirect.com/science/article/abs/pii/S0962892420301434|Trends in Cell Biology]] (2020). The review paper suggested by Christi.